![](https://www.microbiometimes.com/wp-content/uploads/2020/10/shutterstock_1508197382-326x245.jpg)
Market Reports
The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry
Abstract Year 2020 has been a pivotal year for microbiome-focused drug companies. This year the industry saw the release of two much-anticipated Phase 3 studies, which showed positive results and set the stage for new […]